Pullback creates buying opportunity in this biotech stock: Oppenheimer

July 23, 2026 5:00 PM

Oppenheimer reiterated an Outperform rating and $210 price target on one biotech name in a note Thursday, saying a sharp ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found